Top

Published in:

01-04-2008 | Original Paper

UV radiation exposure, skin type and lymphoid malignancies: results of a French case–control study

Authors: L. Grandin, L. Orsi, X. Troussard, A. Monnereau, C. Berthou, P. Fenaux, G. Marit, P. Soubeyran, F. Huguet, N. Milpied, M. Leporrier, D. Hemon, J. Clavel

Published in: Cancer Causes & Control | Issue 3/2008

Abstract

Objectives

Investigating the relationship between skin type, UV exposure, and lymphoid malignancies (LM).

Methods

We conducted a hospital-based case–control study in France, including 813 incident cases of non-Hodgkin’s lymphoma (NHL), Hodgkin’s lymphoma (HL), lymphoproliferative syndrome (LPS) or multiple myeloma and 748 controls.

Results

Positive associations between HL and blond/red hair (OR = 1.8 [0.8–3.8]), very fair/fair skin (OR = 1.6 [1.0–2.5]) were observed. High propensity to burn was associated with HL (OR = 1.5 [1.0–2.2]) and LPS (OR = 1.4 [1.0–2.1]). Poor ability to tan was significantly associated with HL (OR = 1.7 [1.0–2.8]). Having light hair with high propensity to burn was associated with NHL (OR = 1.5 [0.9–2.5]) and significantly with HL (OR = 3.4 [1.4–8.4]). Having dark hair with high propensity to burn was significantly associated with LPS (OR = 1.5 [1.0–2.2]). The associations with HL and NHL were significant for men only, with significant interactions. Outdoors activities since leaving school or in the last decade were not related to LM. Only an almost negative trend was observed. Prior exposure to artificial UV was not associated with LM.

Conclusion

These results suggest a positive association between the most reactive and palest skin types and NHL or HL in men and do not rule out a slight negative relationship between UV exposure and LM.

Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J (1992) Epidemiology of non-Hodgkin lymphoma in Connecticut 1935–1988. Cancer 70:840–849PubMedCrossRef

Cartwright R, McNally R, Staines A (1994) The increasing incidence of non-Hodgkin’s lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 14:387–394PubMedCrossRef

Norval M (2006) The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog Biophys Mol Biol 92:108–118PubMedCrossRef

Ekstrom-Smedby K (2006) Epidemiology and etiology of non-Hodgkin lymphoma—a review. Acta Oncol 45:258–271PubMedCrossRef

Hu S, Federman DG, Ma F, Kirsner RS (2005) Skin cancer and non-Hodgkin’s lymphoma: examining the link. Dermatol Surg 31:76–82PubMedCrossRef

McMichael AJ, Giles GG (1996) Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin’s lymphoma? Br J Cancer 73:945–950PubMed

Bentham G (1996) Association between incidence of non-Hodgkin’s lymphoma and solar ultraviolet radiation in England and Wales. BMJ 312:1128–1131PubMed

Adami J, Gridley G, Nyren O et al (1999) Sunlight and non-Hodgkin’s lymphoma: a population-based cohort study in Sweden. Int J Cancer 80:641–645PubMedCrossRef

van WE, Savitz DA (2001) Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med 43:548–553.CrossRef

10.

Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N (2001) Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 12:552–557PubMedCrossRef

11.

Hughes AM, Armstrong BK, Vajdic CM et al (2004) Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer 110:429–434PubMedCrossRef

12.

Newton R (1995) Non-Hodgkin’s lymphoma and skin cancer. American data refute ultraviolet hypothesis. BMJ 311:750–751PubMed

13.

Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF Jr (1996) Non-Hodgkin’s lymphoma and sunlight. J Natl Cancer Inst 88:298–300PubMedCrossRef

14.

Freedman DM, Zahm SH, Dosemeci M (1997) Residential and occupational exposure to sunlight and mortality from non-Hodgkin’s lymphoma: composite (threefold) case–control study. BMJ 314:1451–1455PubMed

15.

Grant WB (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867–1875PubMedCrossRef

16.

Grant WB (2003) Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 164:371–377PubMed

17.

Hu S, Ma F, Collado-Mesa F, Kirsner RS (2004) Ultraviolet radiation and incidence of non-Hodgkin’s lymphoma among Hispanics in the United States. Cancer Epidemiol Biomarkers Prev 13:59–64PubMedCrossRef

18.

Hughes AM, Armstrong BK, Vajdic CM et al (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case–control study. Int J Cancer 112:865–871PubMedCrossRef

19.

Smedby KE, Hjalgrim H, Melbye M et al (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97:199–209PubMedCrossRef

20.

Weihkopf T, Becker N, Nieters A et al (2007) Sun exposure and malignant lymphoma: a population-based case–control study in Germany. Int J Cancer 120:2445–2451PubMedCrossRef

21.

Hartge P, Lim U, Freedman DM et al (2006) Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 17:1045–1052PubMedCrossRef

22.

Kricker A, Armstrong B (2006) Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol 92:132–139PubMedCrossRef

23.

Holick MF (2006) Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 92:49–59PubMedCrossRef

24.

Orsi L, Troussard X, Monnereau A et al (2007) Occupation and lymphoid malignancies: results from a French case–control study. J Occup Environ Med 49 (in press)

25.

Monnereau A, Orsi L, Troussard X et al (2007) History of infections and vaccinations and risk of lymphoid neoplasms: does influenza immunization reduce the risk? Leukemia 21:2075–2079PubMedCrossRef

26.

Nakatsuka S, Aozasa K (2006) Epidemiology and pathologic features of Hodgkin lymphoma. Int J Hematol 83:391–397PubMedCrossRef

27.

Guinot C, Malvy DJ, Latreille J et al (2005) Sun-reactive Skin Type in 4912 French adults participating in the SU.VI.MAX study. Photochem Photobiol 81:934–940PubMedCrossRef

Title: UV radiation exposure, skin type and lymphoid malignancies: results of a French case–control study
Authors: L. Grandin
L. Orsi
X. Troussard
A. Monnereau
C. Berthou
P. Fenaux
G. Marit
P. Soubeyran
F. Huguet
N. Milpied
M. Leporrier
D. Hemon
J. Clavel
Publication date: 01-04-2008
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 3/2008
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-007-9093-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2008

The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure

Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study

Dietary phytoestrogen intake—lignans and isoflavones—and breast cancer risk (Canada)

Are work-related stressors associated with diagnosis of more advanced stages of incident breast cancers?

Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.

Risk of thyroid cancer among Iranian immigrants in Sweden

Keynote webinar | Spotlight on antibody–drug conjugates in cancer